OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Navigating the complexities of drug development for inflammatory bowel disease
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 32
Sailish Honap, Vipul Jairath, Silvio Danese, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 7, pp. 546-562
Closed Access | Times Cited: 32
Showing 26-50 of 32 citing articles:
Metabolomics for enhanced clinical understanding of inflammatory bowel disease
Theresa Louise Boye, Alexander Hammerhøj, Ole Haagen Nielsen, et al.
Life Sciences (2024) Vol. 359, pp. 123238-123238
Open Access | Times Cited: 1
Theresa Louise Boye, Alexander Hammerhøj, Ole Haagen Nielsen, et al.
Life Sciences (2024) Vol. 359, pp. 123238-123238
Open Access | Times Cited: 1
A Polysaccharide Metal Phenolic Network Nanocomposite for Theranostic Applications in Inflammatory Bowel Disease
Jianlun Hu, Xiaofeng Wang, Qi Sun, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 1
Jianlun Hu, Xiaofeng Wang, Qi Sun, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 1
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints
Sailish Honap, Vipul Jairath, Bruce E. Sands, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
Sailish Honap, Vipul Jairath, Bruce E. Sands, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
Do placebos harm patients in IBD trials?
Fernando Gomollón
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 11, pp. 970-972
Closed Access
Fernando Gomollón
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 11, pp. 970-972
Closed Access
The landscape of new therapeutic opportunities for IBD
Andrés Hurtado-Lorenzo, Jennifer L Swantek
Advances in pharmacology (2024), pp. 1-83
Closed Access
Andrés Hurtado-Lorenzo, Jennifer L Swantek
Advances in pharmacology (2024), pp. 1-83
Closed Access
Immunological Profiles, Oxidative Stress Biomarkers and Plasma Cholinesterase Activities in Patients with Immune-Mediated Inflammatory Diseases Treated in a Clinic in Duhok, Iraq
Rabie G. Abdullah, F. K. Mohammad, Souzan Eassa
Acta Medica Bulgarica (2024) Vol. 51, Iss. 4, pp. 41-46
Open Access
Rabie G. Abdullah, F. K. Mohammad, Souzan Eassa
Acta Medica Bulgarica (2024) Vol. 51, Iss. 4, pp. 41-46
Open Access
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management
Luisa Bertin, Martina Crepaldi, Miriana Zanconato, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Luisa Bertin, Martina Crepaldi, Miriana Zanconato, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Reevaluating the Association Between Neonatal Inflammatory Markers and Early-Onset IBD Risk
Lichao Yang, G. Liu, Lijuan Yuan
Gastroenterology (2024)
Closed Access
Lichao Yang, G. Liu, Lijuan Yuan
Gastroenterology (2024)
Closed Access
